THERAPEUTIC ANTI-BODY SERVICES TECHNOLOGIES (Q2035366): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item)
(‎Changed an Item: Label in wikidata changed)
label / enlabel / en
 
THERAPEUTIC ANTI-BODY SERVICES TECHNOLOGIES

Revision as of 11:20, 17 March 2020

Project in Italy financed by DG Regio
Language Label Description Also known as
English
THERAPEUTIC ANTI-BODY SERVICES TECHNOLOGIES
Project in Italy financed by DG Regio

    Statements

    0 references
    188,379.49 Euro
    0 references
    376,758.97 Euro
    0 references
    50.000001327108414 percent
    0 references
    12 December 2016
    0 references
    6 July 2019
    0 references
    EXIRIS S.R.L.
    0 references
    0 references

    41°53'35.95"N, 12°28'58.55"E
    0 references
    GLI ANTICORPI SONO AGENTI TERAPEUTICI DI GRANDE SUCCESSO CHE VENGONO UTILIZZATI PER IL TRATTAMENTO DI MALATTIE ONCOLOGICHE, INFIAMMATORIE, AUTO IMMUNI E CARDIOVASCOLARI. IL NUMERO DI FARMACI BASATI SU ANTICORPI Ê IN CONTINUA CRESCITA (Italian)
    0 references

    Identifiers

    F81B18000200007
    0 references